Global Lancets Market Growth 2025-2031

The global Lancets market size is predicted to grow from US$ 1638 million in 2025 to US$ 2170 million in 2031; it is expected to grow at a CAGR of 4.8% from 2025 to 2031.

Lancets are a pricking needle used to obtain drops of blood for testing. Lancets are being increasingly used by patients affected by cardiovascular and endocrine-related complications. Lancets are designed to only be used once, and then disposed of in a safe way. These devices are being used for cholesterol and glucose tests, heelstick screening tests or phenylketonuria (PKU) tests in newborns, as well as for severely burned or scarred emergency patients, extremely obese patients and thrombotic-tendency patients.

Market Drivers:

Growing prevalence of chronic diseases: The rise in chronic conditions like diabetes, which require regular blood glucose monitoring, is a significant driver for lancet demand. As the number of diabetes patients increases globally, the need for lancets continues to grow.

Technological advancements in lancets: Innovations such as ultra-thin needles, painless lancet designs, and easy-to-use lancet devices improve user experience, making blood sampling more comfortable and encouraging more frequent use.

Increase in home-based healthcare: The trend toward home healthcare and self-monitoring for various conditions, especially diabetes, has driven the use of lancets. This allows patients to monitor their health in a more convenient and cost-effective way, increasing the market for these devices.

Aging population: The growing elderly population is more prone to chronic diseases like diabetes, requiring regular blood monitoring. This demographic shift is a major factor pushing the demand for lancets and other monitoring devices.

Rising awareness of preventive healthcare: Increasing awareness of the importance of regular health monitoring, especially for managing conditions like diabetes, has led to higher adoption of lancets for routine blood tests and glucose monitoring.

Market Challenges:

Competition from alternative technologies: Non-invasive blood glucose monitoring methods (such as continuous glucose monitors or sensor-based systems) are gaining traction, potentially reducing the reliance on traditional lancets for blood sampling.

High recurring costs for patients: Lancets are single-use devices, and the recurring cost for people who need frequent testing can become a financial burden, particularly in low-income regions or for uninsured patients, limiting market growth.

Infection risks: Improper or repeated use of lancets can lead to infections, particularly if they are not disposed of properly or if reused by mistake, which poses a health risk and deters their use.

Environmental concerns: Lancets contribute to medical waste, as they are disposable devices, raising concerns about environmental impact. This could lead to regulatory pressures or a shift toward more sustainable alternatives.

Regulatory compliance and approval hurdles: The lancet market is subject to stringent regulations and approval processes from health authorities. This can slow down the introduction of new products and innovations, delaying their availability in the market.

The classification of Lancets includes Ordinary Lancets and Safety Lancets. In 2023, Ordinary Lancets accounted for a share of 61.81% in the global Lancets market. With several hospitals and healthcare facilities converting to safety lancets, this market share is poised for declined. Americas is the largest consumption place, with a consumption market share nearly 40 % in 2022. Following Americas, Europe is the second largest consumption place with the consumption market share of 30 %.

LP Information, Inc. (LPI) ' newest research report, the “Lancets Industry Forecast” looks at past sales and reviews total world Lancets sales in 2024, providing a comprehensive analysis by region and market sector of projected Lancets sales for 2025 through 2031. With Lancets sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Lancets industry.

This Insight Report provides a comprehensive analysis of the global Lancets landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Lancets portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Lancets market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Lancets and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Lancets.

This report presents a comprehensive overview, market shares, and growth opportunities of Lancets market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Safety Lancets
Ordinary Lancets

Segmentation by Application:
Children's Fingertip Blood Tests
Glucose Tests
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Roche
Lifescan
BD
Ascensia
Abbott
B. Braun
ARKRAY
Terumo
I-SENS
Nipro
Cardinal Health
ICU Medical
Sarstedt
Sinocare
Yicheng
Yuwell
Greiner Bio One
Guangzhou iCare Medical
Shandong Lianfa
Tianjin Huahong
Owen Mumford
HemoCue
HTL-STREFA
UltiMed
SteriLance Medical

Key Questions Addressed in this Report

What is the 10-year outlook for the global Lancets market?

What factors are driving Lancets market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Lancets market opportunities vary by end market size?

How does Lancets break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.